Navigation Links
Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
Date:9/17/2007

CARY, N.C., Sept. 17 /PRNewswire/ -- Grammy Winner Marc Cohn, best known for the hit single "Walking in Memphis," will lend his voice and talents to the challenge of AIDS in Africa by performing at the third annual Carolina HopeFest in Cary on September 30th. Cohn will be joined in the festival by Mat Kearney, Glen Phillips (of Toad the Wet Sprocket), Derek Webb, and local favorites Thad Cockrell and David Spencer.

The Carolina HopeFest, which benefits Beacon of Hope in Nairobi, Kenya, will be the third stop on Cohn's nationwide tour, the first time in more than a decade that Cohn has toured with a full band. The performance at the Koka Booth Amphitheater also comes just days before the release of Cohn's first new album in nearly nine years, entitled Join the Parade.

"It's been a while since I've been on tour with a full band and I'm really looking forward to it," said Cohn. "Playing the older songs with a full band and now doing some of the newer tracks from Join The Parade for fans is going to be a lot of fun."

"We are thrilled to have one of the great American songwriters express his concern for people halfway around the world by joining in this event," said Jenny Nicholson, co-producer of the Carolina HopeFest. "We are looking forward to having his fans come out for this rare, full-band performance, and help us celebrate the hope that Beacon brings to women and children in Africa."

Beacon of Hope brings in women and children affected by the HIV / AIDS epidemic in the slums of Kenya and gives them medical care, vocational training, education, and a means to earn a living.

The festival, sponsored by Morrisville-based computer maker Lenovo, will also feature a second stage where acoustic acts will play.

Doors open at 1:30 and music continues until 10 PM. HopeFest tickets are available at the amphitheatre box office, online at Ticketmaster, and at Beantraders coffee shops. More information is available at

SOURCE Carolina HopeFest
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
4. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...Data Published in ,The Lancet, and Presented at ES...- Results from a new international,study, the GISS...d dose of,omega-3 acid ethyl esters reduced all ca...scular reasons in patients with chronic heart,fail...nline version of ,The,Lancet, and were presented a...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Pre...tCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) announced...,an investigational anti-CTLA-4 antibody, in mela...ons at the 33rd Congress of the European Society,f...-16, 2008 in Stockholm.,Many of the following abst...
(Date:9/3/2008)...ays: Wrong Question Asked. Wrong Children Studied....PRNewswire-USNewswire/ -- A Centers for Disease,Co...aims there is no link,between the MMR vaccine and ... this study does nothing to dispel the growing pub...aises several questions concerning design,and meth...
(Date:9/3/2008)...SELS, Belgium and GENEVA, Sept. 3 /- ...lestone in CHO based monoclonal antibody,productio...over 31 grams,per liter. This record level was acc...logies: (1) a high-performance stable Selexis CHO,... leading scientists at,Selexis SA using their prop...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3How fast youll age is written in the bones TAU research finds 16411 1How fast youll age is written in the bones TAU research finds 16411 2Boston College biologists build a better mouse model for cancer research 16409 1Boston College biologists build a better mouse model for cancer research 16409 2UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 1UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 2UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 3UNICEF Launches Initiative to Provide Assistance to Children With Disabilities in Vietnam 16407 4An Eye Opening Look at Insomnia 16405 1An Eye Opening Look at Insomnia 16405 2
... 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc....nical trial of GVAX immunotherapy,for pancreatic c...ney Kimmel Cancer Center. The trial enrolled 60 pa...d GVAX after surgical,resection of their tumor and...n overall survival for these patients was previous...
...000, 2002 , CHICAGO/DARMSTADT, Germany, June 4, 20...d today at the American Society of,Clinical Oncolo...e,clinical activity of cilengitide in patients wit...rly aggressive form of brain tumor.,Cilengitide is...he,tumor and its vasculature. , Fifty-two patients...
Other Medicine Technology:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 2Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 3Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 4Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 5Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 2Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 3Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 4Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 5
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...esity is a major risk factor for cardiovascular di...rt attack// is more even if the rest of the body i...hat the key predictor of risk is the relationship ...ed waist-to-hip ratio predicts an increased risk o...
...nt has repeated its plea to doctors over prescript...uld save ?85 millions in the coming year if GPs// ...rimary Care Trusts (PCTs) can prescribe generic ve...astatin, which are two of five ‘statin’ drugs that...
...investigating the potential beneficial effects of ...ctive effects of anti-TNFa treatment in aging," ap... of Pathology. This study shows hope for signific... by inactivating TNFa, which has been linked to bl...
...our high blood pressure might just be your inflamm...nce suggests that inflammation, a part of the immu... Alzheimer’s and diabetes, may also help translate...ssure. “There is a concept that hypertension is a...
Other Medicine News:Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 3
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...tional high-end microplate reader with outstanding... modes., Fluorescence Intensity - FRET , Fluores... HTRF, AlphaScreen , Luminescence , , , PHERAst...der with fastest read times. The ultimate solution...
Medicine Products: